VX16-809-116: A Phase 3, Rollover Study to Evaluate the Safety of Long term Treatment with Lumacaftor/Ivacaftor Combination Therapy in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutati

Project: Research project

Project Details

StatusFinished
Effective start/end date6/12/17 → 7/3/19

Funding

  • Vertex Pharmaceuticals Incorporated